Compare SLDB & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | BWMX |
|---|---|---|
| Founded | 2013 | 1995 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 674.4M | 644.3M |
| IPO Year | 2017 | 2019 |
| Metric | SLDB | BWMX |
|---|---|---|
| Price | $8.29 | $17.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $16.36 | ★ $27.83 |
| AVG Volume (30 Days) | ★ 1.2M | 58.5K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 9.11% |
| EPS Growth | ★ 34.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,094,000.00 | N/A |
| Revenue This Year | N/A | $18.17 |
| Revenue Next Year | N/A | $25.68 |
| P/E Ratio | ★ N/A | $12.54 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.79 | $8.04 |
| 52 Week High | $8.87 | $19.79 |
| Indicator | SLDB | BWMX |
|---|---|---|
| Relative Strength Index (RSI) | 63.34 | 51.87 |
| Support Level | $6.38 | $17.50 |
| Resistance Level | $8.87 | $19.40 |
| Average True Range (ATR) | 0.51 | 0.79 |
| MACD | 0.14 | -0.06 |
| Stochastic Oscillator | 96.98 | 40.16 |
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
Betterware de Mexico SAPI de CV is a company in the consumer product goods industry focused on home organization and beauty and personal care products, commercialized through person-to-person selling. The Group operates through two segments: Home organization under the Betterware brand, including kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, bedroom and wellness. Products are sold through catalogues and distributed through distributors and associates. The Beauty and personal care (B&PC) segment under the JAFRA brand, which generates maximum revenue, includes fragrance, color, skin care and toiletries, distributed through leaders and consultants. The Group operates in Mexico, which generates maximum revenue, the United States and Latam.